Dr. Tasha Morrison received her bachelor degree in biology from Temple University in 2005. Her interests in basic science research led her to start a summer internship in the laboratory of Dr. Elizabeth Henske at Fox Chase Cancer Center, which led to a post-baccalaureate position funded by the NIH/NIDDK to study molecular mechanisms of renal malignancy in tuberous sclerosis. In 2008, Dr. Morrison moved with Dr. Henske to Brigham and Women’s Hospital as a research assistant, and changed her focus to better understand estrogen’s role in the malignancy of lymphangioleiomyomatosis. During her time at Brigham, she received a master degree in public health at Boston University. In 2012, Dr. Morrison started a doctoral program in molecular and translational medicine at Boston University School of Medicine, where she characterized a novel long noncoding RNA, and determined its role in regulating hemoglobin expression in red blood cells. During her doctoral training, she was awarded a F31 predoctoral fellowship grant funded by the NIH/NHLBI. After successfully defending her doctoral thesis, in 2017 Dr. Morrison joined the laboratory of Dr. John O’Shea as a postdoctoral fellow.
Dr. Morrison’s overall research goal is to understand the role of long noncoding RNAs (lncRNAs) using genomic approaches that will uncover novel molecular mechanisms that regulate cell function. Her current focus is to understand how lncRNAs regulate the differentiation and activation of natural killer (NK) cells to determine their significance to innate immunity.